Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.

Abstract

The reduction in plasma concentration of S1P after infarction could lessen its protective action on cardiomyocyte viability. The observed reduction in S1P level might be associated with the standard antiplatelet treatment given to patients since thrombocytes are one of the major sources of plasma S1P.